SEC Form 4/A · accession 0001179110-18-002001
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John Oyler
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Mar 16, 2017
Accepted (ET)
Feb 13, 2018 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | holding | — | — | — | 24,853,455 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The total reported in Column 5 has been adjusted to correct an error in the total holding first reflected on the Form 4 filed on March 20, 2017 and the subsequent Form 4s.